etoposide has been researched along with eye in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Jampel, HD; Leong, KW; Quigley, HA; Uppal, P | 1 |
| Ghiasi, H; Henderson, G; Inman, M; Jones, C; Nesburn, AB; Perng, GC; Wechsler, SL | 1 |
| Lin, S; Mao, Y; Wu, Z; Yang, H; Zheng, J | 1 |
| Dyer, MA; Egorin, M; Gray, JK; Laurie, NA; Leggas, M; Relling, M; Stewart, C; Zhang, J | 1 |
| Rodríguez-Arnaiz, R; Sortibrán, AN; Téllez, MG | 1 |
| Chung, SE; Ham, DI; Koo, HH; Sa, HS; Sung, KW; Yoo, KH | 1 |
| Ahmad, I; Aqil, M; Hazari, PP; Mishra, AK; Pandit, J; Sultana, Y | 1 |
| Biswas, NR; Chawla, B; Halder, N; Maithani, D; Patnaik, SK; Thavaraj, V; Velpandian, T | 1 |
| Pai, RV; Vavia, PR | 1 |
9 other study(ies) available for etoposide and eye
| Article | Year |
|---|---|
Pharmacokinetics of etoposide delivery by a bioerodible drug carrier implanted at glaucoma surgery.
Topics: Animals; Biodegradation, Environmental; Drug Carriers; Drug Implants; Etoposide; Eye; Glaucoma; Male; Rabbits; Trabeculectomy; Wound Healing | 1994 |
Region of herpes simplex virus type 1 latency-associated transcript sufficient for wild-type spontaneous reactivation promotes cell survival in tissue culture.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Cell Line; Cell Survival; Disease Models, Animal; Etoposide; Eye; Gene Expression Regulation; Herpes Simplex; Herpesvirus 1, Human; Introns; Male; Promoter Regions, Genetic; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rabbits; RNA, Viral; Sequence Deletion; Transfection; Virus Activation; Virus Latency | 2001 |
Measurement of intraocular concentrations of etoposide after systemic and local administration.
Topics: Administration, Topical; Animals; Antineoplastic Agents, Phytogenic; Aqueous Humor; Biological Availability; Conjunctiva; Etoposide; Eye; Infusions, Intravenous; Injections; Rabbits; Retinal Neoplasms; Retinoblastoma; Tissue Distribution; Vitreous Body | 2004 |
Topotecan combination chemotherapy in two new rodent models of retinoblastoma.
Topics: Animals; Animals, Newborn; Antineoplastic Agents; Apoptosis; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Etoposide; Eye; Humans; Mice; Mice, Knockout; Rats; Retinal Neoplasms; Retinoblastoma; Time Factors; Topotecan; Vincristine; Xenograft Model Antitumor Assays | 2005 |
Genotoxic profile of inhibitors of topoisomerases I (camptothecin) and II (etoposide) in a mitotic recombination and sex-chromosome loss somatic eye assay of Drosophila melanogaster.
Topics: Animals; Camptothecin; Crosses, Genetic; Drosophila melanogaster; Enzyme Inhibitors; Etoposide; Eye; Female; Male; Mitosis; Mutagens; Recombination, Genetic; Sex Chromosome Aberrations; Topoisomerase I Inhibitors | 2006 |
Clinical manifestations and treatment of retinoblastoma in Korea.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Eye; Eye Enucleation; Female; Humans; Infant; Korea; Male; Neoplasm Recurrence, Local; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Treatment Outcome; Vincristine | 2008 |
Optimization by design of etoposide loaded solid lipid nanoparticles for ocular delivery: Characterization, pharmacokinetic and deposition study.
Topics: Analysis of Variance; Animals; Calorimetry, Differential Scanning; Drug Delivery Systems; Drug Liberation; Etoposide; Excipients; Eye; Lipids; Male; Nanoparticles; Particle Size; Rabbits; Rats, Wistar; Regression Analysis; Solubility; Spectroscopy, Fourier Transform Infrared | 2019 |
Comparison of ocular pharmacokinetics of etoposide and its nanoemulsion after subtenon administration in rabbits.
Topics: Animals; Biological Availability; Drug Compounding; Emulsions; Etoposide; Eye; Female; Injections, Intraocular; Male; Nanotechnology; Rabbits | 2019 |
Chitosan oligosaccharide enhances binding of nanostructured lipid carriers to ocular mucins: Effect on ocular disposition.
Topics: Administration, Topical; Animals; Antineoplastic Agents, Phytogenic; Chitosan; Coumarins; Drug Carriers; Drug Delivery Systems; Etoposide; Eye; Lipids; Mucins; Nanostructures; Oligosaccharides; Rabbits; Rats; Rats, Sprague-Dawley; Tissue Distribution; Toxicity Tests | 2020 |